Polyene Antifungal [EPC]

Polyene Antifungal [EPC] was reported 40450 times

These side effects are most commonly reported by patients taking drugs of the Polyene Antifungal [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 4515
1 OFF LABEL USE 2925
2 NAUSEA 2407
3 DIARRHOEA 2156
4 PNEUMONIA 2099
5 FATIGUE 2033
6 PYREXIA 1894
7 DYSPNOEA 1782
8 VOMITING 1722
9 DEATH 1564
10 CONDITION AGGRAVATED 1538
11 ACUTE KIDNEY INJURY 1436
12 PAIN 1412
13 HEADACHE 1274
14 SEPSIS 1173
15 RENAL FAILURE 1147
16 RASH 1138
17 FEBRILE NEUTROPENIA 1125
18 COUGH 1115
19 ANAEMIA 1087
20 ASTHENIA 1043
21 URINARY TRACT INFECTION 973
22 PRODUCT USE IN UNAPPROVED INDICATION 961
23 DIZZINESS 946
24 CHRONIC KIDNEY DISEASE 942
25 NEUTROPENIA 929
26 MALAISE 900
27 WEIGHT DECREASED 897
28 FALL 891
29 ARTHRALGIA 887
30 HYPOTENSION 874
31 ABDOMINAL PAIN 823
32 DECREASED APPETITE 805
33 ANXIETY 791
34 RESPIRATORY FAILURE 782
35 THROMBOCYTOPENIA 781
36 CONSTIPATION 769
37 OEDEMA PERIPHERAL 767
38 PRURITUS 757
39 CANDIDA INFECTION 724
40 DRUG INTERACTION 719
41 HYPERTENSION 715
42 PAIN IN EXTREMITY 711
43 DEHYDRATION 697
44 BACK PAIN 693
45 INFECTION 690
46 DISEASE PROGRESSION 667
47 SEPTIC SHOCK 651
48 INSOMNIA 640
49 FUNGAL INFECTION 594
50 RENAL IMPAIRMENT 592
51 DEPRESSION 555
52 SINUSITIS 555
53 PANCYTOPENIA 552
54 GASTROOESOPHAGEAL REFLUX DISEASE 539
55 DYSPHAGIA 535
56 MULTIPLE ORGAN DYSFUNCTION SYNDROME 529
57 WEIGHT INCREASED 528
58 ATRIAL FIBRILLATION 526
59 HYPOKALAEMIA 526
60 GENERAL PHYSICAL HEALTH DETERIORATION 510
61 PLEURAL EFFUSION 505
62 CHEST PAIN 500
63 ORAL CANDIDIASIS 500
64 HAEMOGLOBIN DECREASED 492
65 BLOOD CREATININE INCREASED 483
66 GAIT DISTURBANCE 482
67 CONFUSIONAL STATE 472
68 STOMATITIS 467
69 PRODUCT USE ISSUE 463
70 COVID-19 462
71 LEUKOPENIA 462
72 ASTHMA 454
73 PRODUCT DOSE OMISSION ISSUE 454
74 MUSCLE SPASMS 451
75 ERYTHEMA 449
76 DRUG HYPERSENSITIVITY 448
77 PLATELET COUNT DECREASED 430
78 ASPERGILLUS INFECTION 425
79 TREMOR 421
80 HYPERSENSITIVITY 413
81 MUCOSAL INFLAMMATION 412
82 ABDOMINAL PAIN UPPER 408
83 CHILLS 408
84 PULMONARY EMBOLISM 402
85 PERIPHERAL SWELLING 401
86 SOMNOLENCE 399
87 NASOPHARYNGITIS 394
88 DRUG RESISTANCE 388
89 WHEEZING 381
90 HEPATIC ENZYME INCREASED 380
91 CELLULITIS 378
92 BLOOD PRESSURE INCREASED 377
93 OROPHARYNGEAL PAIN 377
94 TACHYCARDIA 376
95 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 371
96 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 371
97 MUSCULAR WEAKNESS 368
98 NEUROPATHY PERIPHERAL 362
99 CHOLELITHIASIS 357
100 WHITE BLOOD CELL COUNT DECREASED 356
101 BRONCHOPULMONARY ASPERGILLOSIS 354
102 CARDIAC ARREST 353
103 RENAL FAILURE ACUTE 351
104 ALOPECIA 350
105 HYPOAESTHESIA 350
106 CARDIAC FAILURE CONGESTIVE 349
107 MYALGIA 340
108 GASTROINTESTINAL HAEMORRHAGE 339
109 BLOOD BILIRUBIN INCREASED 338
110 FEELING ABNORMAL 338
111 BRONCHITIS 335
112 TREATMENT FAILURE 331
113 HYPONATRAEMIA 330
114 ABDOMINAL DISCOMFORT 318
115 HEPATOTOXICITY 318
116 MUCORMYCOSIS 315
117 ABDOMINAL DISTENSION 314
118 SWELLING 314
119 PULMONARY OEDEMA 308
120 ALANINE AMINOTRANSFERASE INCREASED 304
121 HYPOXIA 304
122 PARAESTHESIA 302
123 DEEP VEIN THROMBOSIS 300
124 TOXIC EPIDERMAL NECROLYSIS 298
125 TOXICITY TO VARIOUS AGENTS 298
126 END STAGE RENAL DISEASE 294
127 BLOOD GLUCOSE INCREASED 292
128 PRODUCTIVE COUGH 292
129 SEIZURE 292
130 EMOTIONAL DISTRESS 290
131 STAPHYLOCOCCAL INFECTION 289
132 OXYGEN SATURATION DECREASED 288
133 CEREBROVASCULAR ACCIDENT 283
134 DYSPEPSIA 282
135 VISION BLURRED 282
136 CONTUSION 281
137 CHEST DISCOMFORT 280
138 CYTOMEGALOVIRUS INFECTION 280
139 INFLUENZA 278
140 HOSPITALISATION 273
141 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 272
142 MALIGNANT NEOPLASM PROGRESSION 272
143 GASTROINTESTINAL DISORDER 270
144 URTICARIA 269
145 JOINT SWELLING 267
146 SYNCOPE 267
147 THROMBOSIS 266
148 OSTEOPOROSIS 265
149 OSTEOARTHRITIS 264
150 OEDEMA 262
151 HEART RATE INCREASED 261
152 DRY MOUTH 260
153 THERAPY NON-RESPONDER 260
154 HAEMORRHAGE 257
155 UPPER RESPIRATORY TRACT INFECTION 256
156 ASPARTATE AMINOTRANSFERASE INCREASED 251
157 SCHIZOPHRENIA 251
158 EPISTAXIS 250
159 MEMORY IMPAIRMENT 250
160 LOSS OF CONSCIOUSNESS 248
161 DYSPNOEA EXERTIONAL 243
162 INTENTIONAL PRODUCT USE ISSUE 243
163 MYOCARDIAL INFARCTION 243
164 NEPHROPATHY TOXIC 239
165 DRUG INTOLERANCE 236
166 LETHARGY 235
167 HERPES ZOSTER 234
168 MENTAL STATUS CHANGES 234
169 C-REACTIVE PROTEIN INCREASED 233
170 ILLNESS 232
171 EYE PAIN 231
172 DIABETES MELLITUS 229
173 ACUTE RESPIRATORY FAILURE 227
174 HYPERKALAEMIA 227
175 BLISTER 225
176 DYSPHONIA 225
177 RESPIRATORY DISTRESS 222
178 RENAL INJURY 220
179 ENCEPHALOPATHY 219
180 MOUTH ULCERATION 217
181 SKIN EXFOLIATION 214
182 VISUAL IMPAIRMENT 213
183 HYPERHIDROSIS 212
184 BALANCE DISORDER 210
185 PALPITATIONS 209
186 PSYCHOTIC DISORDER 209
187 CARDIAC FAILURE 208
188 LYMPHADENOPATHY 205
189 DISEASE RECURRENCE 204
190 HALLUCINATION 203
191 DRY SKIN 200
192 NEPHROGENIC ANAEMIA 200
193 MIGRAINE 199
194 PNEUMONITIS 199
195 STEVENS-JOHNSON SYNDROME 198
196 SWELLING FACE 198
197 PSORIASIS 197
198 INCORRECT DOSE ADMINISTERED 196
199 ORAL PAIN 196
200 ORTHOSTATIC HYPOTENSION 196
201 ARTHRITIS 195
202 OVERDOSE 194
203 PSEUDOMONAS INFECTION 193
204 ELECTROCARDIOGRAM QT PROLONGED 191
205 INFUSION RELATED REACTION 191
206 NASAL CONGESTION 191
207 ANHEDONIA 190
208 BLOOD POTASSIUM DECREASED 190
209 BRADYCARDIA 188
210 INFLAMMATION 187
211 ASCITES 185
212 METABOLIC ACIDOSIS 185
213 HIATUS HERNIA 182
214 HYPOMANIA 182
215 INJURY 182
216 COLITIS 181
217 HAEMOPTYSIS 180
218 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 180
219 INJECTION SITE PAIN 179
220 JAUNDICE CHOLESTATIC 179
221 MULTI-ORGAN FAILURE 179
222 HYPERGLYCAEMIA 178
223 TRANSPLANT REJECTION 178
224 RESPIRATORY DISORDER 177
225 DYSGEUSIA 174
226 LOWER RESPIRATORY TRACT INFECTION 174
227 AGITATION 173
228 SLEEP APNOEA SYNDROME 170
229 BLOOD PRESSURE DECREASED 169
230 TREATMENT NONCOMPLIANCE 168
231 BLOOD ALKALINE PHOSPHATASE INCREASED 166
232 SKIN ULCER 166
233 ENTEROCOCCAL INFECTION 165
234 MUSCULOSKELETAL STIFFNESS 165
235 RASH ERYTHEMATOUS 165
236 RHINORRHOEA 165
237 HEPATIC FAILURE 164
238 LUNG DISORDER 163
239 PANCREATITIS 162
240 CYTOKINE RELEASE SYNDROME 161
241 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 161
242 SKIN LESION 160
243 SLEEP DISORDER 160
244 RED BLOOD CELL COUNT DECREASED 158
245 WHITE BLOOD CELL COUNT INCREASED 157
246 DELIRIUM 156
247 CATARACT 155
248 MENINGITIS CRYPTOCOCCAL 155
249 DRUG LEVEL INCREASED 154
250 GRAFT VERSUS HOST DISEASE 154
251 NASAL POLYPS 154
252 PATHOGEN RESISTANCE 154
253 RENAL TUBULAR NECROSIS 154
254 BURNING SENSATION 153
255 DRUG-INDUCED LIVER INJURY 153
256 HAEMATURIA 153
257 NEPHROLITHIASIS 153
258 TUBULOINTERSTITIAL NEPHRITIS 153
259 BACTERAEMIA 152
260 BACTERIAL INFECTION 152
261 BONE MARROW FAILURE 151
262 DRUG DOSE OMISSION 151
263 HAEMATOCRIT DECREASED 151
264 VIRAL INFECTION 151
265 ACUTE RESPIRATORY DISTRESS SYNDROME 150
266 CYSTITIS 149
267 FLUSHING 149
268 LIVER FUNCTION TEST ABNORMAL 148
269 NEUTROPHIL COUNT DECREASED 148
270 PULMONARY HYPERTENSION 148
271 CARDIAC MURMUR 147
272 FLUID RETENTION 147
273 ARRHYTHMIA 146
274 RESPIRATORY TRACT INFECTION 146
275 ECONOMIC PROBLEM 145
276 FOETAL EXPOSURE DURING PREGNANCY 145
277 NECK PAIN 145
278 PNEUMONIA ASPIRATION 144
279 SHOCK 144
280 THROAT IRRITATION 142
281 CARDIAC DISORDER 141
282 KLEBSIELLA INFECTION 141
283 MOBILITY DECREASED 141
284 PNEUMONIA FUNGAL 140
285 DISSEMINATED INTRAVASCULAR COAGULATION 139
286 GASTRITIS 139
287 HOT FLUSH 139
288 HYPOPHAGIA 138
289 RASH MACULO-PAPULAR 138
290 RENAL DISORDER 138
291 DYSURIA 137
292 ECZEMA 137
293 RHINITIS ALLERGIC 137
294 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 137
295 MUSCULOSKELETAL PAIN 136
296 VERTIGO 136
297 FLATULENCE 135
298 INFLUENZA LIKE ILLNESS 135
299 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 135
300 ELECTROLYTE IMBALANCE 134
301 PNEUMOTHORAX 134
302 PULMONARY MASS 134
303 STRESS 134
304 CLOSTRIDIUM DIFFICILE COLITIS 133
305 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 133
306 HAEMORRHOIDS 132
307 HYPOGLYCAEMIA 132
308 BONE PAIN 131
309 BRONCHIECTASIS 131
310 DEPRESSED LEVEL OF CONSCIOUSNESS 131
311 ATELECTASIS 130
312 CRYPTOCOCCOSIS 130
313 HEPATIC FUNCTION ABNORMAL 130
314 LUNG INFILTRATION 130
315 SYSTEMIC CANDIDA 130
316 OBSTRUCTIVE AIRWAYS DISORDER 129
317 THERAPEUTIC RESPONSE DECREASED 129
318 URINARY INCONTINENCE 129
319 ENDOPHTHALMITIS 128
320 BLOOD UREA INCREASED 127
321 BRAIN OEDEMA 127
322 RECTAL HAEMORRHAGE 127
323 HAEMATOCHEZIA 126
324 BODY TEMPERATURE INCREASED 125
325 MATERNAL EXPOSURE DURING PREGNANCY 125
326 CANDIDIASIS 124
327 GAMMA-GLUTAMYLTRANSFERASE INCREASED 124
328 RESTLESSNESS 124
329 TRICUSPID VALVE INCOMPETENCE 124
330 UNEVALUABLE EVENT 123
331 CONVULSION 122
332 LIP SWELLING 122
333 LIVER DISORDER 122
334 TACHYPNOEA 122
335 ABSCESS 121
336 CARDIO-RESPIRATORY ARREST 121
337 PERICARDIAL EFFUSION 121
338 ADVERSE DRUG REACTION 120
339 ESCHERICHIA INFECTION 120
340 HYPERBILIRUBINAEMIA 120
341 RASH PRURITIC 120
342 LUNG NEOPLASM MALIGNANT 119
343 OSTEOMYELITIS 119
344 ANAPHYLACTIC REACTION 118
345 FUNGAEMIA 118
346 HYPOMAGNESAEMIA 118
347 RHEUMATOID ARTHRITIS 118
348 URINARY RETENTION 118
349 VISUAL ACUITY REDUCED 118
350 COAGULOPATHY 116
351 HAEMATOMA 116
352 INTERSTITIAL LUNG DISEASE 116
353 TOOTH INFECTION 116
354 POLLAKIURIA 115
355 SARCOIDOSIS 115
356 EAR INFECTION 114
357 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 114
358 HYPERPARATHYROIDISM SECONDARY 114
359 CLOSTRIDIUM DIFFICILE INFECTION 113
360 DEVICE RELATED INFECTION 113
361 HYPOTHYROIDISM 113
362 PLASMA CELL MYELOMA 113
363 SPINAL OSTEOARTHRITIS 113
364 CEREBRAL HAEMORRHAGE 112
365 EXPOSURE DURING PREGNANCY 112
366 FUNGAL SKIN INFECTION 112
367 ILL-DEFINED DISORDER 112
368 NIGHT SWEATS 112
369 DISCOMFORT 111
370 DYSARTHRIA 111
371 HEMIPARESIS 111
372 NERVOUS SYSTEM DISORDER 111
373 HAEMATEMESIS 110
374 BLOOD POTASSIUM INCREASED 109
375 IMPAIRED HEALING 109
376 NO ADVERSE EVENT 109
377 THERAPY INTERRUPTED 109
378 DRY EYE 108
379 FLUID OVERLOAD 108
380 PAIN IN JAW 108
381 OESOPHAGITIS 107
382 OSTEOPENIA 107
383 COGNITIVE DISORDER 106
384 SWOLLEN TONGUE 106
385 UNRESPONSIVE TO STIMULI 106
386 BLOOD PRESSURE FLUCTUATION 105
387 BLOOD SODIUM DECREASED 105
388 GLOSSODYNIA 105
389 IRON DEFICIENCY ANAEMIA 105
390 LEUKOCYTOSIS 105
391 LUNG INFECTION 105
392 NEUROTOXICITY 105
393 NEUTROPENIC SEPSIS 105
394 ODYNOPHAGIA 105
395 PREMATURE BABY 105
396 AMNESIA 104
397 CARDIOMEGALY 104
398 IMPAIRED GASTRIC EMPTYING 104
399 MITRAL VALVE INCOMPETENCE 104
400 NEURALGIA 104
401 CEREBRAL INFARCTION 103
402 INTESTINAL OBSTRUCTION 103
403 IRRITABILITY 103
404 JAUNDICE 103
405 UPPER GASTROINTESTINAL HAEMORRHAGE 103
406 INTERNATIONAL NORMALISED RATIO INCREASED 102
407 SKIN DISCOLOURATION 102
408 SURGERY 102
409 BLOOD CHOLESTEROL INCREASED 101
410 GENERALISED OEDEMA 101
411 PULMONARY CONGESTION 101
412 SKIN INFECTION 101
413 SPEECH DISORDER 101
414 TRANSAMINASES INCREASED 101
415 BK VIRUS INFECTION 100
416 CHOLESTASIS 100
417 DIVERTICULITIS 100
418 PRODUCT QUALITY ISSUE 100
419 SKIN DISORDER 100
420 ACUTE MYELOID LEUKAEMIA 99
421 COLITIS ULCERATIVE 99
422 FUSARIUM INFECTION 99
423 HEPATIC STEATOSIS 99
424 APLASTIC ANAEMIA 98
425 BLOOD ALBUMIN DECREASED 98
426 DIVERTICULUM 98
427 FEELING HOT 98
428 UROSEPSIS 98
429 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 97
430 TOTAL LUNG CAPACITY INCREASED 97
431 CENTRAL NERVOUS SYSTEM LESION 96
432 EMPHYSEMA 96
433 HIP FRACTURE 96
434 HYDRONEPHROSIS 96
435 RASH MACULAR 96
436 RIB FRACTURE 96
437 COMA 95
438 CONJUNCTIVITIS 95
439 FAILURE TO THRIVE 95
440 GASTROENTERITIS 95
441 ILEUS 95
442 KIDNEY TRANSPLANT REJECTION 95
443 SPLENOMEGALY 95
444 COMPLICATIONS OF TRANSPLANTED KIDNEY 94
445 VENTRICULAR TACHYCARDIA 94
446 GASTROENTERITIS VIRAL 93
447 HEPATITIS 93
448 ADVERSE EVENT 92
449 CORONARY ARTERY DISEASE 92
450 HYPOCALCAEMIA 92
451 OLIGURIA 92
452 ORAL HERPES 92
453 PULMONARY HAEMORRHAGE 92
454 RESTLESS LEGS SYNDROME 92
455 SINUS TACHYCARDIA 92
456 STAPHYLOCOCCAL BACTERAEMIA 92
457 BLOOD TEST ABNORMAL 91
458 NEOPLASM MALIGNANT 91
459 ARTHROPATHY 90
460 CHRONIC SINUSITIS 90
461 DISORIENTATION 90
462 IMMUNODEFICIENCY 90
463 OSTEONECROSIS OF JAW 90
464 PREMATURE DELIVERY 90
465 PRODUCT DOSE OMISSION 90
466 TASTE DISORDER 90
467 TYPE 2 DIABETES MELLITUS 90
468 APHASIA 89
469 ASPERGILLOSIS 88
470 PRESYNCOPE 88
471 UVEITIS 88
472 BLOOD LACTATE DEHYDROGENASE INCREASED 87
473 CEREBRAL ASPERGILLOSIS 87
474 GOUT 87
475 LYMPHOCYTE COUNT DECREASED 87
476 CIRCULATORY COLLAPSE 86
477 NEOPLASM PROGRESSION 86
478 PSORIATIC ARTHROPATHY 86
479 SUICIDAL IDEATION 86
480 TRANSFUSION 86
481 ANGIOEDEMA 85
482 CARDIOGENIC SHOCK 85
483 HYPERLIPIDAEMIA 85
484 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 85
485 PNEUMOCYSTIS JIROVECII PNEUMONIA 85
486 PNEUMONIA BACTERIAL 85
487 DYSKINESIA 84
488 HEAD INJURY 84
489 LYMPHOPENIA 84
490 MEDICATION ERROR 84
491 OSTEONECROSIS 84
492 TOOTH DISORDER 84
493 OESOPHAGEAL CANDIDIASIS 83
494 PRODUCT PRESCRIBING ISSUE 83
495 PROTEINURIA 83
496 SMALL INTESTINAL OBSTRUCTION 83
497 CARDIOMYOPATHY 82
498 HALLUCINATION, VISUAL 82
499 INTENTIONAL PRODUCT MISUSE 82
500 LIVER FUNCTION TEST INCREASED 82
501 LOCALISED INFECTION 82
502 MALNUTRITION 82
503 ORAL DISORDER 82
504 PANCREATITIS ACUTE 82
505 TOOTHACHE 82
506 DRUG LEVEL BELOW THERAPEUTIC 81
507 CHOLECYSTITIS 80
508 DRUG LEVEL DECREASED 80
509 EAR PAIN 80
510 INTRACRANIAL PRESSURE INCREASED 80
511 PHARYNGITIS 80
512 BONE DISORDER 79
513 CROHN^S DISEASE 79
514 DEPRESSED MOOD 79
515 DISSEMINATED MUCORMYCOSIS 79
516 SCEDOSPORIUM INFECTION 79
517 THERAPEUTIC RESPONSE UNEXPECTED 79
518 TRANSIENT ISCHAEMIC ATTACK 79
519 INTERVERTEBRAL DISC DEGENERATION 78
520 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 78
521 SINUSITIS FUNGAL 78
522 STAPHYLOCOCCAL SEPSIS 78
523 ADRENAL INSUFFICIENCY 77
524 GASTRIC ULCER 77
525 HERPES SIMPLEX 77
526 HYPERSOMNIA 77
527 MUSCULOSKELETAL CHEST PAIN 77
528 WOUND 77
529 ACUTE MYOCARDIAL INFARCTION 76
530 COVID-19 PNEUMONIA 76
531 DECUBITUS ULCER 76
532 EYE IRRITATION 76
533 FAECES DISCOLOURED 76
534 FEAR 76
535 LEFT VENTRICULAR HYPERTROPHY 76
536 RETCHING 76
537 ROAD TRAFFIC ACCIDENT 76
538 SEASONAL ALLERGY 76
539 CHROMATURIA 75
540 ENCEPHALITIS 75
541 FEEDING DISORDER 75
542 FOOT FRACTURE 75
543 TONGUE ULCERATION 75
544 AGRANULOCYTOSIS 74
545 BLINDNESS 74
546 INTERVERTEBRAL DISC PROTRUSION 74
547 KIDNEY INFECTION 74
548 GAIT INABILITY 73
549 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 73
550 HAEMOLYTIC ANAEMIA 73
551 LIMB INJURY 73
552 OBESITY 73
553 PALLOR 73
554 VITAMIN D DEFICIENCY 73
555 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 72
556 CHOROIDITIS 72
557 DIABETIC KETOACIDOSIS 72
558 DYSSTASIA 72
559 HEART RATE DECREASED 72
560 OCULAR HYPERAEMIA 72
561 VENOOCCLUSIVE LIVER DISEASE 72
562 ANGINA PECTORIS 71
563 EPILEPSY 71
564 INJECTION SITE BRUISING 71
565 INJECTION SITE ERYTHEMA 71
566 LIVER INJURY 71
567 NECROSIS 71
568 ORAL DISCOMFORT 71
569 ORAL FUNGAL INFECTION 71
570 RENAL CYST 71
571 RHINOVIRUS INFECTION 71
572 SUPRAVENTRICULAR TACHYCARDIA 71
573 SYSTEMIC MYCOSIS 71
574 BASAL CELL CARCINOMA 70
575 BRAIN ABSCESS 70
576 DIASTOLIC DYSFUNCTION 70
577 JOINT STIFFNESS 70
578 CARPAL TUNNEL SYNDROME 69
579 DIALYSIS 69
580 FIBROMYALGIA 69
581 HEPATOSPLENOMEGALY 69
582 HYPOALBUMINAEMIA 69
583 INTRAOCULAR PRESSURE INCREASED 69
584 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 69
585 POST PROCEDURAL COMPLICATION 69
586 PULMONARY MUCORMYCOSIS 69
587 SPUTUM INCREASED 69
588 BONE DENSITY DECREASED 68
589 DISSEMINATED CRYPTOCOCCOSIS 68
590 EATING DISORDER 68
591 GENERALISED TONIC-CLONIC SEIZURE 68
592 HYPERCALCAEMIA 68
593 RESPIRATORY SYNCYTIAL VIRUS INFECTION 68
594 SYSTEMIC LUPUS ERYTHEMATOSUS 68
595 URINE OUTPUT DECREASED 68
596 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 67
597 BLOOD GLUCOSE DECREASED 67
598 FEMALE GENITAL TRACT FISTULA 67
599 LABORATORY TEST ABNORMAL 67
600 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 67
601 RESPIRATORY TRACT CONGESTION 67
602 THROAT TIGHTNESS 67
603 CYTOMEGALOVIRUS VIRAEMIA 66
604 CYTOPENIA 66
605 GRANULOMA 66
606 HEPATIC CYTOLYSIS 66
607 HYDROCEPHALUS 66
608 IMMUNE SYSTEM DISORDER 66
609 NERVOUSNESS 66
610 RHABDOMYOLYSIS 66
611 ROTATOR CUFF SYNDROME 66
612 THROMBOTIC MICROANGIOPATHY 66
613 EJECTION FRACTION DECREASED 65
614 HISTOPLASMOSIS DISSEMINATED 65
615 IRRITABLE BOWEL SYNDROME 65
616 LACTIC ACIDOSIS 65
617 MENTAL DISORDER 65
618 TINNITUS 65
619 UNDERDOSE 65
620 ARTERIOSCLEROSIS 64
621 DERMATITIS 64
622 HAEMODYNAMIC INSTABILITY 64
623 HEPATOMEGALY 64
624 HYPOACUSIS 64
625 HYSTERECTOMY 64
626 MELAENA 64
627 SINUS DISORDER 64
628 SPINAL FRACTURE 64
629 WOUND INFECTION 64
630 DRUG TOXICITY 63
631 REBOUND ACID HYPERSECRETION 63
632 RECTAL PROLAPSE 63
633 THERAPY CESSATION 63
634 UPPER-AIRWAY COUGH SYNDROME 63
635 VENTRICULAR FIBRILLATION 63
636 GLYCOSYLATED HAEMOGLOBIN INCREASED 62
637 LIMB DISCOMFORT 62
638 PULMONARY FIBROSIS 62
639 SHOCK HAEMORRHAGIC 62
640 SQUAMOUS CELL CARCINOMA OF SKIN 62
641 APHTHOUS ULCER 61
642 BRAIN HERNIATION 61
643 DENTAL CARIES 61
644 ESCHERICHIA URINARY TRACT INFECTION 61
645 FLANK PAIN 61
646 HAEMORRHAGE INTRACRANIAL 61
647 HOSPICE CARE 61
648 MULTIPLE SCLEROSIS RELAPSE 61
649 RASH GENERALISED 61
650 RESPIRATORY SYMPTOM 61
651 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 61
652 ACNE 60
653 CYTOMEGALOVIRUS INFECTION REACTIVATION 60
654 GLOMERULAR FILTRATION RATE DECREASED 60
655 HYPERTHYROIDISM 60
656 INTENTIONAL DOSE OMISSION 60
657 ISCHAEMIC STROKE 60
658 LACRIMATION INCREASED 60
659 MASS 60
660 MYELOSUPPRESSION 60
661 PERITONITIS 60
662 SPINAL COMPRESSION FRACTURE 60
663 ABNORMAL BEHAVIOUR 59
664 AORTIC ARTERIOSCLEROSIS 59
665 DEAFNESS 59
666 EYE DISORDER 59
667 EYE SWELLING 59
668 FREQUENT BOWEL MOVEMENTS 59
669 HAEMODIALYSIS 59
670 INSURANCE ISSUE 59
671 LOCAL SWELLING 59
672 MOOD SWINGS 59
673 SUBDURAL HAEMATOMA 59
674 ABDOMINAL PAIN LOWER 58
675 BACTERIAL SEPSIS 58
676 BLOOD CULTURE POSITIVE 58
677 FULL BLOOD COUNT DECREASED 58
678 HYPOGAMMAGLOBULINAEMIA 58
679 IMMUNE RECONSTITUTION SYNDROME 58
680 SQUAMOUS CELL CARCINOMA 58
681 TENDONITIS 58
682 BENIGN PROSTATIC HYPERPLASIA 57
683 CHRONIC GRAFT VERSUS HOST DISEASE 57
684 DISTURBANCE IN ATTENTION 57
685 IMMUNOSUPPRESSION 57
686 INFLAMMATORY MARKER INCREASED 57
687 PROCEDURAL PAIN 57
688 RESPIRATORY ARREST 57
689 SECRETION DISCHARGE 57
690 TENDERNESS 57
691 TOOTH FRACTURE 57
692 CYSTITIS HAEMORRHAGIC 56
693 DIVERTICULUM INTESTINAL 56
694 MYOCARDITIS 56
695 PHOTOSENSITIVITY REACTION 56
696 BLOOD PRESSURE SYSTOLIC INCREASED 55
697 BLOOD TRIGLYCERIDES INCREASED 55
698 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55
699 MUSCLE ATROPHY 55
700 PYELONEPHRITIS 55
701 RASH PAPULAR 55
702 SINUS CONGESTION 55
703 ACCIDENTAL OVERDOSE 54
704 BLOOD MAGNESIUM DECREASED 54
705 BUNDLE BRANCH BLOCK LEFT 54
706 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 54
707 EMOTIONAL DISORDER 54
708 EPSTEIN-BARR VIRUS INFECTION 54
709 INJECTION SITE REACTION 54
710 MULTIPLE SCLEROSIS 54
711 ORAL MUCOSAL BLISTERING 54
712 OTITIS MEDIA 54
713 RENAL FAILURE CHRONIC 54
714 TARDIVE DYSKINESIA 54
715 VASCULAR DEVICE INFECTION 54
716 ACUTE GRAFT VERSUS HOST DISEASE 53
717 BLOOD CALCIUM DECREASED 53
718 EMBOLISM VENOUS 53
719 FEMUR FRACTURE 53
720 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 53
721 JOINT INJURY 53
722 KYPHOSIS 53
723 SKIN FISSURES 53
724 TORSADE DE POINTES 53
725 ACTINIC KERATOSIS 52
726 ANKLE FRACTURE 52
727 ATAXIA 52
728 CHOKING 52
729 FOLLICULITIS 52
730 HEPATIC CIRRHOSIS 52
731 IMPAIRED QUALITY OF LIFE 52
732 MENINGITIS 52
733 MUSCULOSKELETAL DISCOMFORT 52
734 PRODUCT DOSE OMISSION IN ERROR 52
735 SCIATICA 52
736 AGEUSIA 51
737 BREAST CANCER METASTATIC 51
738 BRONCHOSPASM 51
739 DECREASED ACTIVITY 51
740 DIPLOPIA 51
741 GASTRIC DISORDER 51
742 HYPOPHOSPHATAEMIA 51
743 HYPOVOLAEMIA 51
744 PHOTOPHOBIA 51
745 POSTOPERATIVE WOUND INFECTION 51
746 CYANOSIS 50
747 DEVICE ISSUE 50
748 HISTOPLASMOSIS 50
749 INFUSION SITE PAIN 50
750 LUNG NEOPLASM 50
751 METASTASES TO CENTRAL NERVOUS SYSTEM 50
752 NEPHROPATHY 50
753 NEUTROPHIL COUNT INCREASED 50
754 NO THERAPEUTIC RESPONSE 50
755 PHARYNGITIS STREPTOCOCCAL 50
756 PLATELET COUNT INCREASED 50
757 QUALITY OF LIFE DECREASED 50
758 TRICHOSPORON INFECTION 50
759 VASCULITIS 50
760 ANAPHYLACTIC SHOCK 49
761 DISABILITY 49
762 DISSEMINATED ASPERGILLOSIS 49
763 FEELING COLD 49
764 MYOPATHY 49
765 RHINOCEREBRAL MUCORMYCOSIS 49
766 TOOTH LOSS 49
767 VAGINAL HAEMORRHAGE 49
768 AGGRESSION 48
769 ALTERED STATE OF CONSCIOUSNESS 48
770 DRUG EFFECT DECREASED 48
771 EMBOLISM 48
772 GALLBLADDER DISORDER 48
773 INCONTINENCE 48
774 PETECHIAE 48
775 PRE-EXISTING CONDITION IMPROVED 48
776 RENAL ARTERY STENOSIS 48
777 SALPINGO-OOPHORECTOMY UNILATERAL 48
778 SKIN LACERATION 48
779 ACIDOSIS 47
780 BREATH SOUNDS ABNORMAL 47
781 DEMENTIA 47
782 GINGIVAL BLEEDING 47
783 GINGIVITIS 47
784 HEART RATE IRREGULAR 47
785 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 47
786 LEFT VENTRICULAR DYSFUNCTION 47
787 LOWER LIMB FRACTURE 47
788 MOVEMENT DISORDER 47
789 PARAESTHESIA ORAL 47
790 PSEUDOMONAL SEPSIS 47
791 APPLICATION SITE PAIN 46
792 BLOOD CREATINE PHOSPHOKINASE INCREASED 46
793 DELAYED GRAFT FUNCTION 46
794 FUNGAL ENDOCARDITIS 46
795 HYPERTRANSAMINASAEMIA 46
796 INFUSION SITE ERYTHEMA 46
797 INJECTION SITE SWELLING 46
798 PANIC ATTACK 46
799 PATENT DUCTUS ARTERIOSUS 46
800 SKIN HAEMORRHAGE 46
801 ULCER 46
802 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 45
803 ANGER 45
804 AORTIC VALVE INCOMPETENCE 45
805 BURSITIS 45
806 CYTOMEGALOVIRUS TEST POSITIVE 45
807 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 45
808 LYMPHOMA 45
809 MULTIPLE ALLERGIES 45
810 MYELODYSPLASTIC SYNDROME 45
811 PHARYNGEAL SWELLING 45
812 POOR QUALITY SLEEP 45
813 POST PROCEDURAL HAEMORRHAGE 45
814 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 45
815 SEDATION 45
816 SPUTUM DISCOLOURED 45
817 VISCERAL LEISHMANIASIS 45
818 ANURIA 44
819 ASPIRATION 44
820 CANDIDA SEPSIS 44
821 CHEILITIS 44
822 DERMATITIS CONTACT 44
823 ENTEROCOLITIS 44
824 HYPERVOLAEMIA 44
825 INFUSION SITE SWELLING 44
826 LARGE INTESTINE POLYP 44
827 NOCTURIA 44
828 PERIPHERAL SENSORY NEUROPATHY 44
829 PNEUMONIA PSEUDOMONAL 44
830 STREPTOCOCCAL INFECTION 44
831 ACTIVITIES OF DAILY LIVING IMPAIRED 43
832 ADENOVIRUS INFECTION 43
833 BLADDER DISORDER 43
834 BLOOD URINE PRESENT 43
835 DRUG DEPENDENCE 43
836 DRUG LEVEL ABOVE THERAPEUTIC 43
837 ENDOCARDITIS 43
838 ERYTHEMA MULTIFORME 43
839 EYE PRURITUS 43
840 FISTULA 43
841 LIGAMENT SPRAIN 43
842 METASTASES TO BONE 43
843 METASTASES TO LIVER 43
844 POLYNEUROPATHY 43
845 SKIN MASS 43
846 SKIN NECROSIS 43
847 SKIN REACTION 43
848 THERAPY PARTIAL RESPONDER 43
849 TOOTH ABSCESS 43
850 ACUTE HEPATIC FAILURE 42
851 ANOREXIA 42
852 APHONIA 42
853 BEDRIDDEN 42
854 BLOOD PRESSURE ABNORMAL 42
855 EOSINOPHILIA 42
856 EXOSTOSIS 42
857 GLAUCOMA 42
858 INJECTION SITE PRURITUS 42
859 LYMPHOEDEMA 42
860 MULTIPLE FRACTURES 42
861 PARAINFLUENZAE VIRUS INFECTION 42
862 PRODUCT STORAGE ERROR 42
863 SALIVARY HYPERSECRETION 42
864 AZOTAEMIA 41
865 DERMATITIS ATOPIC 41
866 DRUG ERUPTION 41
867 FACE OEDEMA 41
868 FULL BLOOD COUNT ABNORMAL 41
869 GASTROINTESTINAL PAIN 41
870 GINGIVAL PAIN 41
871 HYPERNATRAEMIA 41
872 LOWER GASTROINTESTINAL HAEMORRHAGE 41
873 NOCARDIOSIS 41
874 NODULE 41
875 RALES 41
876 SPINAL STENOSIS 41
877 STATUS EPILEPTICUS 41
878 THYROID DISORDER 41
879 CAROTID ARTERIOSCLEROSIS 40
880 COLD SWEAT 40
881 DIABETIC NEUROPATHY 40
882 ECCHYMOSIS 40
883 ELECTROCARDIOGRAM ABNORMAL 40
884 ENTEROBACTER INFECTION 40
885 ESCHERICHIA BACTERAEMIA 40
886 HEPATIC LESION 40
887 HEPATOCELLULAR INJURY 40
888 PARKINSON^S DISEASE 40
889 PROTHROMBIN TIME PROLONGED 40
890 PULMONARY ARTERIAL HYPERTENSION 40
891 SCAR 40
892 SEPTIC EMBOLUS 40
893 SKIN CANCER 40
894 VENOOCCLUSIVE DISEASE 40
895 CACHEXIA 39
896 CRYING 39
897 DIABETES MELLITUS INADEQUATE CONTROL 39
898 DRUG ADMINISTRATION ERROR 39
899 FACIAL PAIN 39
900 GASTROINTESTINAL INFECTION 39
901 HYPOPROTEINAEMIA 39
902 INTESTINAL PERFORATION 39
903 LARYNGITIS 39
904 LOBAR PNEUMONIA 39
905 MACULAR DEGENERATION 39
906 PNEUMONIA CRYPTOCOCCAL 39
907 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 39
908 RENAL TUBULAR DISORDER 39
909 TUMOUR LYSIS SYNDROME 39
910 ABASIA 38
911 DRUG EFFECT INCOMPLETE 38
912 HYPOVOLAEMIC SHOCK 38
913 MEAN CELL VOLUME INCREASED 38
914 MICTURITION URGENCY 38
915 MYOCARDIAL ISCHAEMIA 38
916 MYOCLONUS 38
917 NEUTROPENIC COLITIS 38
918 PULSELESS ELECTRICAL ACTIVITY 38
919 SKIN ABRASION 38
920 SUBARACHNOID HAEMORRHAGE 38
921 SUSPECTED OFF LABEL USE 38
922 TRANSPLANT FAILURE 38
923 VENTRICULAR EXTRASYSTOLES 38
924 WITHDRAWAL SYNDROME 38
925 ACCIDENTAL EXPOSURE TO PRODUCT 37
926 AORTIC DILATATION 37
927 ARTERIOSCLEROSIS CORONARY ARTERY 37
928 DERMATITIS EXFOLIATIVE 37
929 DEVICE MALFUNCTION 37
930 DIFFUSE LARGE B-CELL LYMPHOMA 37
931 EYE INFECTION 37
932 FOOT DEFORMITY 37
933 FRACTURE 37
934 HEPATIC ENCEPHALOPATHY 37
935 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37
936 LIVER ABSCESS 37
937 LUNG CONSOLIDATION 37
938 MULTIPLE INJURIES 37
939 PLEURISY 37
940 PNEUMONIA KLEBSIELLA 37
941 PSYCHOLOGICAL TRAUMA 37
942 STENOTROPHOMONAS INFECTION 37
943 SYNOVITIS 37
944 VITAMIN D DECREASED 37
945 CARDIOVASCULAR DISORDER 36
946 CAROTID ARTERY STENOSIS 36
947 CLOSTRIDIUM TEST POSITIVE 36
948 CUSHING^S SYNDROME 36
949 DEFORMITY 36
950 GRAFT VERSUS HOST DISEASE IN SKIN 36
951 HEMIPLEGIA 36
952 HYPOAESTHESIA ORAL 36
953 ISCHAEMIA 36
954 MULTIPLE-DRUG RESISTANCE 36
955 MUSCLE SPASTICITY 36
956 PRESCRIBED UNDERDOSE 36
957 RHINITIS 36
958 SKIN BURNING SENSATION 36
959 THERAPEUTIC PRODUCT EFFECT DECREASED 36
960 THIRST 36
961 TONGUE DISCOLOURATION 36
962 TOOTH EXTRACTION 36
963 UPPER LIMB FRACTURE 36
964 URINARY TRACT INFECTION ENTEROCOCCAL 36
965 BLOOD COUNT ABNORMAL 35
966 BLOOD CREATININE DECREASED 35
967 BUNDLE BRANCH BLOCK RIGHT 35
968 CEREBRAL ISCHAEMIA 35
969 CYST 35
970 ESSENTIAL HYPERTENSION 35
971 EYE INFECTION FUNGAL 35
972 HYPERCAPNIA 35
973 HYPERURICAEMIA 35
974 HYPOKINESIA 35
975 HYPOTHERMIA 35
976 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35
977 INCREASED TENDENCY TO BRUISE 35
978 INFUSION SITE EXTRAVASATION 35
979 ISCHAEMIC CARDIOMYOPATHY 35
980 MENTAL IMPAIRMENT 35
981 MIDDLE INSOMNIA 35
982 ORAL INFECTION 35
983 PARANOIA 35
984 PURULENT DISCHARGE 35
985 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35
986 SNEEZING 35
987 VARICELLA ZOSTER VIRUS INFECTION 35
988 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 34
989 GRAND MAL CONVULSION 34
990 HAEMATOLOGICAL INFECTION 34
991 HYPERCHOLESTEROLAEMIA 34
992 INTERVERTEBRAL DISC SPACE NARROWING 34
993 METASTASES TO LUNG 34
994 MOUTH HAEMORRHAGE 34
995 MUSCLE TWITCHING 34
996 NEUROLOGICAL DECOMPENSATION 34
997 PAIN OF SKIN 34
998 PAPULE 34
999 PSEUDOMONAL BACTERAEMIA 34